Global Biomanufacturing Platform Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global Biomanufacturing Platform market size will reach US$ 1454 million by 2031.
Biomanufacturing refers to a manufacturing method that uses organisms or their mechanisms (such as cells, microorganisms, viruses, etc.) to synthesize products or promote production processes on an industrial scale. It is widely used in the fields of medicine, food, chemicals, materials, etc. It replaces traditional petrochemical routes to achieve more efficient and sustainable production, and is becoming an important support for global green transformation and high value-added innovation.
Biomanufacturing Platform refers to an integrated and scalable industrial solution system that supports the entire process of biological products (such as antibodies, vaccines, cell and gene therapies, mRNA, fermentation metabolites, etc.) from early research and development, process development, pilot verification to GMP commercial production.
United States market for Biomanufacturing Platform is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Biomanufacturing Platform is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Biomanufacturing Platform is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Biomanufacturing Platform players cover Biotechnet, BioFactura, Evotec, Xcellerex, Manus Bio Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Biomanufacturing Platform Industry Forecast” looks at past sales and reviews total world Biomanufacturing Platform sales in 2024, providing a comprehensive analysis by region and market sector of projected Biomanufacturing Platform sales for 2025 through 2031. With Biomanufacturing Platform sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biomanufacturing Platform industry.
This Insight Report provides a comprehensive analysis of the global Biomanufacturing Platform landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Biomanufacturing Platform portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biomanufacturing Platform market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biomanufacturing Platform and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biomanufacturing Platform.
This report presents a comprehensive overview, market shares, and growth opportunities of Biomanufacturing Platform market by product type, application, key players and key regions and countries.
Segmentation by Type:
Clinical Manufacturing
Upscaling
Commercial Manufacturing
Segmentation by Application:
Pharmaceuticals
Agriculture
Energy
Food
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Biotechnet
BioFactura
Evotec
Xcellerex
Manus Bio Inc.
Batavia Biosciences
Samabriva
LFB biomanufacturing
Arsenale Bioyards Srl
EnginZyme
Alpine Bio
Bio Base Europe Pilot Plant
Merck KGaA
Please note: The report will take approximately 2 business days to prepare and deliver.
Biomanufacturing refers to a manufacturing method that uses organisms or their mechanisms (such as cells, microorganisms, viruses, etc.) to synthesize products or promote production processes on an industrial scale. It is widely used in the fields of medicine, food, chemicals, materials, etc. It replaces traditional petrochemical routes to achieve more efficient and sustainable production, and is becoming an important support for global green transformation and high value-added innovation.
Biomanufacturing Platform refers to an integrated and scalable industrial solution system that supports the entire process of biological products (such as antibodies, vaccines, cell and gene therapies, mRNA, fermentation metabolites, etc.) from early research and development, process development, pilot verification to GMP commercial production.
United States market for Biomanufacturing Platform is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Biomanufacturing Platform is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Biomanufacturing Platform is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Biomanufacturing Platform players cover Biotechnet, BioFactura, Evotec, Xcellerex, Manus Bio Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Biomanufacturing Platform Industry Forecast” looks at past sales and reviews total world Biomanufacturing Platform sales in 2024, providing a comprehensive analysis by region and market sector of projected Biomanufacturing Platform sales for 2025 through 2031. With Biomanufacturing Platform sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biomanufacturing Platform industry.
This Insight Report provides a comprehensive analysis of the global Biomanufacturing Platform landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Biomanufacturing Platform portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biomanufacturing Platform market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biomanufacturing Platform and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biomanufacturing Platform.
This report presents a comprehensive overview, market shares, and growth opportunities of Biomanufacturing Platform market by product type, application, key players and key regions and countries.
Segmentation by Type:
Clinical Manufacturing
Upscaling
Commercial Manufacturing
Segmentation by Application:
Pharmaceuticals
Agriculture
Energy
Food
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Biotechnet
BioFactura
Evotec
Xcellerex
Manus Bio Inc.
Batavia Biosciences
Samabriva
LFB biomanufacturing
Arsenale Bioyards Srl
EnginZyme
Alpine Bio
Bio Base Europe Pilot Plant
Merck KGaA
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
110 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Biomanufacturing Platform Market Size by Player
- 4 Biomanufacturing Platform by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Biomanufacturing Platform Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
